J.W. Cole Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $512K | Sell |
|
|||||
|
2025
Q2 | $523K | Buy |
|
|||||
|
2025
Q1 | $611K | Buy |
|
|||||
|
2024
Q4 | $447K | Sell |
|
|||||
|
2024
Q3 | $843K | Buy |
|
|||||
|
2024
Q2 | $756K | Sell |
|
|||||
|
2024
Q1 | $727K | Sell |
|
|||||
|
2023
Q4 | $690K | Buy |
|
|||||
|
2023
Q3 | $642K | Sell |
|
|||||
|
2023
Q2 | $633K | Sell |
|
|||||
|
2023
Q1 | $775K | Buy |
|
|||||
|
2022
Q4 | $509K | Sell |
|
|||||
|
2022
Q3 | $495K | Sell |
|
|||||
|
2022
Q2 | $460K | Sell |
|
|||||
|
2022
Q1 | $588K | Sell |
|
|||||
|
2021
Q4 | $539K | Sell |
|
|||||
|
2021
Q3 | $540K | Sell |
|
|||||
|
2021
Q2 | $500K | Buy |
|
|||||
|
2021
Q1 | $207K | Sell |
|
|||||
|
2020
Q4 | $259K | Buy |
|
|||||
|
2020
Q3 | $274K | Buy |
|